title: Scientific letter: A double-blind, randomised, placebo-controlled, 3-month crossover trial of night-time oxygen therapy in advanced systolic heart failure.
authors.forename: Joseph L
authors.initials: JL
authors.lastname: Blackshear
authors.forename: Robert
authors.initials: R
authors.lastname: Safford
authors.forename: Paul
authors.initials: P
authors.lastname: Fredrickson
authors.forename: Colleen
authors.initials: C
authors.lastname: Thomas
authors.forename: Michael
authors.initials: M
authors.lastname: Heckman
authors.forename: Malik
authors.initials: M
authors.lastname: Al-Omari
authors.forename: Joseph
authors.initials: J
authors.lastname: Kaplan
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001315:Australia; D002639:Cheyne-Stokes Respiration / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D054143:Heart Failure, Systolic / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010102:Oxygen Inhalation Therapy; D010919:Placebos; D020127:Recovery of Function; D013997:Time Factors; D016896:Treatment Outcome; D006113:United Kingdom; D014481:United States
chemical_list: D010919:Placebos